DE69531150D1 - Verwendung von biopolymeren zur behandlung der muskeln - Google Patents

Verwendung von biopolymeren zur behandlung der muskeln

Info

Publication number
DE69531150D1
DE69531150D1 DE69531150T DE69531150T DE69531150D1 DE 69531150 D1 DE69531150 D1 DE 69531150D1 DE 69531150 T DE69531150 T DE 69531150T DE 69531150 T DE69531150 T DE 69531150T DE 69531150 D1 DE69531150 D1 DE 69531150D1
Authority
DE
Germany
Prior art keywords
pct
biopolymers
sec
date
pub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531150T
Other languages
English (en)
Other versions
DE69531150T2 (de
Inventor
Denis Barritault
Jean-Pierre Caruelle
Pascal Desgranges
Jean Gautron
Anne Meddahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VALBIOFRANCE PARIS
Original Assignee
VALBIOFRANCE PARIS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VALBIOFRANCE PARIS filed Critical VALBIOFRANCE PARIS
Publication of DE69531150D1 publication Critical patent/DE69531150D1/de
Application granted granted Critical
Publication of DE69531150T2 publication Critical patent/DE69531150T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DE69531150T 1994-03-30 1995-03-29 Verwendung von biopolymeren zur behandlung der muskeln Expired - Lifetime DE69531150T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9403803A FR2718026B1 (fr) 1994-03-30 1994-03-30 Médicament et composition pharmaceutique pour le traitement des muscles.
FR9403803 1994-03-30
PCT/FR1995/000398 WO1995026736A1 (fr) 1994-03-30 1995-03-29 Utilisation de biopolymeres pour le traitement des muscles

Publications (2)

Publication Number Publication Date
DE69531150D1 true DE69531150D1 (de) 2003-07-31
DE69531150T2 DE69531150T2 (de) 2004-04-29

Family

ID=9461614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531150T Expired - Lifetime DE69531150T2 (de) 1994-03-30 1995-03-29 Verwendung von biopolymeren zur behandlung der muskeln

Country Status (9)

Country Link
US (1) US5852003A (de)
EP (1) EP0752862B1 (de)
JP (1) JPH10503472A (de)
AT (1) ATE243521T1 (de)
CA (1) CA2186760C (de)
DE (1) DE69531150T2 (de)
ES (1) ES2202358T3 (de)
FR (1) FR2718026B1 (de)
WO (1) WO1995026736A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
FR2781374B1 (fr) * 1998-07-21 2001-06-29 Denis Barritault Composition antioxydante comprenant au moins un polymere ou biopolymere seul ou associe a la sod
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
WO2002026240A2 (en) * 2000-09-26 2002-04-04 Sidney Kimmel Cancer Center Inhibition of antigen presentation with poorly catabolized polymers
EA010945B1 (ru) 2003-10-28 2008-12-30 Орган Тиссю Реженерасьон Репарасьон Рамплясман - Отр3 Применение биосовместимого полимера для изготовления медицинского устройства
FR2861308A1 (fr) 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
FR2907014B1 (fr) * 2006-10-17 2009-05-15 Engelhard Lyon Sa Utilisation d'actifs cosmetiques pour proteger le fibroblaste growth factor-beta ou fgf-2 de la matrice extracellulaire dans le but de restructurer cette matrice
FR2914191A1 (fr) * 2007-03-29 2008-10-03 Proteins & Peptides Man Composition angiogenique.
US8193220B1 (en) * 2009-08-20 2012-06-05 Alan Brown Scott Method of changing muscle lengths with anesthetic drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461724A1 (fr) * 1979-07-20 1981-02-06 Christine Fougnot Polymeres substitues par des groupes leur conferant des proprietes anti-coagulantes et leur procede de preparation, objets constitues par et/ou comprenant lesdits polymeres et leurs procedes de fabrication, application desdits objets en chirurgie et en medecine, et compositions pharmaceutiques contenant lesdits polymeres substitues
FR2555589B1 (fr) * 1983-11-30 1986-05-16 Choay Sa Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
FR2644066B1 (fr) * 1989-03-09 1994-05-13 Therapeutiques Substitutives Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Also Published As

Publication number Publication date
ES2202358T3 (es) 2004-04-01
DE69531150T2 (de) 2004-04-29
JPH10503472A (ja) 1998-03-31
EP0752862B1 (de) 2003-06-25
WO1995026736A1 (fr) 1995-10-12
EP0752862A1 (de) 1997-01-15
US5852003A (en) 1998-12-22
CA2186760A1 (fr) 1995-10-12
CA2186760C (fr) 2007-10-30
FR2718026A1 (fr) 1995-10-06
ATE243521T1 (de) 2003-07-15
FR2718026B1 (fr) 1997-01-17

Similar Documents

Publication Publication Date Title
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE202785T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DE69523745D1 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
ATE316786T1 (de) Behandlung von mukositis
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69310634D1 (de) Verwendung von Taxol zur Herstellung eines Arzneimittels zur Behandlung von Krebs
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
ATE228846T1 (de) Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
FI964772A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
ATE243521T1 (de) Verwendung von biopolymeren zur behandlung der muskeln
DE69725879D1 (de) VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE320263T1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
ATE147988T1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
ATE200865T1 (de) Verwendung von phosphorderivaten von alkaloiden zur behandlung von endokrinopathien
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин

Legal Events

Date Code Title Description
8364 No opposition during term of opposition